|Bid||41.94 x 1200|
|Ask||41.95 x 3200|
|Day's Range||41.73 - 42.38|
|52 Week Range||38.43 - 48.25|
|Beta (5Y Monthly)||0.34|
|PE Ratio (TTM)||42.26|
|Earnings Date||Jan 31, 2017 - Feb 05, 2017|
|Forward Dividend & Yield||2.40 (5.78%)|
|Ex-Dividend Date||Feb 19, 2020|
|1y Target Est||50.00|
Sanofi (SNY) plans to combine its API commercial activities with six of its European API production sites and spin-off the same into an independent European API company.
The S&P 500 was sitting at an all-time high. Now, it’s experiencing its worst day in two years as the market reacts to the spread of coronavirus. Here’s Barron’s take on everything from oil prices to pharmaceutical stocks to the market as a whole.
Shares of GlaxoSmithKline Plc fell 1.8% in premarket trading on Monday after the drugmaker said it plans to test its technology with Chinese biotech Clover Biopharmaceuticals's vaccine candidate for COVID-19. GSK's adjuvant technology aims to reduce the amount of vaccine per dose, which would, in theory, allow more doses to be produced. COVID-19 is a new coronavirus that was first identified in December in Wuhan, China. Since then, it has spread to 29 other countries, sickening more than 79,000 people and killing at least 2,622 people. There are currently no vaccines or approved therapeutics that can prevent or treat the infection caused by the virus. GSK's adjuvant technology is also being tested for a COVID-19 vaccine by the Coalition for Epidemic Preparedness Innovations, which is working with a number of companies to develop a vaccine for the virus. GSK's stock is up 5% over the past year, while the S&P 500 has gained 20%.
Barron’s reported in late January that the largest vaccine makers were not yet working on COVID-19 programs, yet as the epidemic has progressed, that seems to be changing.
Pfizer stock is on a recent downswing in the wake of lackluster fourth-quarter earnings. But shares are consolidating on the weekly chart. Is the pharmaceutical company a buy right now?
Some of the industry's largest pharmaceutical companies, including Pfizer Inc and Eli Lilly and Co, have developed a blockchain-based system to track prescription drugs across the supply chain to better halt the flow of counterfeit medicines, company officials said on Friday. Some two dozen companies in the industry including drugmakers, distributers, retailers and delivery firms created the blockchain-based MediLedger Network, which it has been testing in the verification of drug returns. Blockchain, which first emerged as the technology underlying virtual currency bitcoin, is a shared database maintained by a network of computers.
Thirty countries and territories have confirmed cases of the illness, called COVID-19; despite the containment measures in place, the number is still on the rise, seemingly unfettered. As the outbreak claims more lives and the number of infected continues to grow, pharmaceutical companies, governments, universities and the World Health Organization are working around the clock to develop a vaccine. Once it is eventually developed, tested and administered, a vaccine will enable an individual’s immune system to effectively respond to the viral infection, preventing its propagation among the inoculated.
British Prime Minister Boris Johnson and his team are reviewing how best to engage with business, his office said on Thursday, after Sky News reported officials were keen to scrap the government's business advice councils. Sky reported Johnson was looking at overhauling five business councils set up in November 2018 by his predecessor Theresa May and that the existing structure was likely to be axed. Johnson has met the co-chairs of the business councils, who include Tesco boss Dave Lewis, BAE Systems Chairman Roger Carr and GlaxoSmithKline Chief Executive Emma Walmsley, only once since he took office in July.
The Zacks Analyst Blog Highlights: Facebook, Netflix, NextEra Energy, GlaxoSmithKline and T-Mobile US
China’s extraordinary economic growth over the past four decades transformed the country into the world’s second-biggest economy. The key to this growth is global trade. China is not only the largest trading partner in the world, but it is also central to a myriad of supply chains.
Sanofi (SNY) and J&J (JNJ) sign deals with BARDA, part of U.S. Department of Health and Human Services, for accelerated development of a vaccine for the newly found coronavirus.
Shares of Glaxo (GSK) lag the industry in a year as generic erosion of some drugs mainly its top-selling drug, Advair offsets strong sales of new drugs.
The life sciences industry is no doubt big business in North Carolina with more than 735 bioscience companies and a total of more than 66,000 industry workers. And the Triangle has its fair share of that pie. Bio/pharma companies are the focus of one of this week’s Triangle Business Journal lists.
Income investors can leverage the increased demand for healthcare into strong total returns, explains Ned Piplovic, editor of DividendInvestor. Here, he reviews two global pharmaceutical firms that are attractive for investors seeking both growth and income.
GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults (18 years and older). With the FDA's approval, Voltaren Arthritis Pain becomes the first and only prescription strength, nonsteroidal anti-inflammatory (NSAID) topical gel for arthritis pain available OTC in the United States.
Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts. An important supplier of generic drugs to the world, Indian companies procure almost 70% of the active pharmaceutical ingredients (APIs) for their medicines from China. India's generic drugmakers say they currently have enough API supplies from China to cover their operations for up to about three months.
A passenger who was repatriated from Wuhan, China, on a U.S. flight and has been in quarantine in San Diego is the latest individual in the U.S. to test positive for the coronavirus, according to media reports.
GlaxoSmithKline plc (LON:GSK) shares fell 4.7% to UK£17.00 in the week since its latest yearly results. The result was...